3 reports of this reaction
6.8% of all HISTAMINE DIHYDROCHLORIDE reports
#1 most reported adverse reaction
COLON CANCER METASTATIC is the #1 most commonly reported adverse reaction for HISTAMINE DIHYDROCHLORIDE, manufactured by ALPHA NUTRITION, LLC. There are 3 FDA adverse event reports linking HISTAMINE DIHYDROCHLORIDE to COLON CANCER METASTATIC. This represents approximately 6.8% of all 44 adverse event reports for this drug.
Patients taking HISTAMINE DIHYDROCHLORIDE who experience colon cancer metastatic should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
COLON CANCER METASTATIC is moderately reported among HISTAMINE DIHYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to colon cancer metastatic, the following adverse reactions have been reported for HISTAMINE DIHYDROCHLORIDE:
COLON CANCER METASTATIC has been reported as an adverse event in 3 FDA reports for HISTAMINE DIHYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
COLON CANCER METASTATIC accounts for approximately 6.8% of all adverse event reports for HISTAMINE DIHYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience colon cancer metastatic while taking HISTAMINE DIHYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.